JP2003505500A - 風邪およびインフルエンザ様疾患に関連した症状の予防および治療のための方法および組成物 - Google Patents

風邪およびインフルエンザ様疾患に関連した症状の予防および治療のための方法および組成物

Info

Publication number
JP2003505500A
JP2003505500A JP2001513401A JP2001513401A JP2003505500A JP 2003505500 A JP2003505500 A JP 2003505500A JP 2001513401 A JP2001513401 A JP 2001513401A JP 2001513401 A JP2001513401 A JP 2001513401A JP 2003505500 A JP2003505500 A JP 2003505500A
Authority
JP
Japan
Prior art keywords
composition
stilbene
phytoalexin
resveratrol
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2001513401A
Other languages
English (en)
Japanese (ja)
Inventor
セイモア ガンテンバーグ，ニコラス
アーネスト ジュニア シンガー，ロバート
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of JP2003505500A publication Critical patent/JP2003505500A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
JP2001513401A 1999-07-30 2000-07-28 風邪およびインフルエンザ様疾患に関連した症状の予防および治療のための方法および組成物 Withdrawn JP2003505500A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36494499A 1999-07-30 1999-07-30
US09/364,944 1999-07-30
PCT/US2000/020658 WO2001008671A2 (en) 1999-07-30 2000-07-28 Method and composition for prophylaxis and treatment of symptoms associated with cold and influenza-like illnesses

Publications (1)

Publication Number Publication Date
JP2003505500A true JP2003505500A (ja) 2003-02-12

Family

ID=23436803

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001513401A Withdrawn JP2003505500A (ja) 1999-07-30 2000-07-28 風邪およびインフルエンザ様疾患に関連した症状の予防および治療のための方法および組成物

Country Status (10)

Country Link
EP (1) EP1221949A2 (zh)
JP (1) JP2003505500A (zh)
CN (1) CN1377262A (zh)
AU (1) AU6240200A (zh)
CA (1) CA2379703A1 (zh)
CO (1) CO5200850A1 (zh)
HK (1) HK1049104A1 (zh)
PE (1) PE20010540A1 (zh)
TR (1) TR200200246T2 (zh)
WO (1) WO2001008671A2 (zh)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007262068A (ja) * 2006-03-28 2007-10-11 Epitech Group Srl 免疫系の一般的反応により引き起こされる病態の治療のための医薬組成物
WO2008136173A1 (ja) * 2007-04-20 2008-11-13 Ochanomizu University スチルベン誘導体を有効成分とする脂肪細胞分化抑制剤
KR20140048212A (ko) 2011-06-29 2014-04-23 가부시키가이샤 롯데 눈 피로 억제 조성물 및 그것을 함유하는 음식품
JP2014530823A (ja) * 2011-10-19 2014-11-20 エヌエーディー ライフ ピーティーワイ リミテッド レスベラトロール医薬組成物

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6878751B1 (en) * 2000-10-19 2005-04-12 Imperial College Of Science Technology And Medicine Administration of resveratrol to treat inflammatory respiratory disorders
ITRM20020562A1 (it) * 2002-11-06 2004-05-07 Sigma Tau Ind Farmaceuti Uso del resveratrolo per la preparazione di un medicamento utile per il trattamento delle infezioni da virus dell'influenza.
AU2006210119B2 (en) 2005-02-04 2011-09-22 Peter Heger Dosage forms of active ingredients containing hydroxystilbene for treating menopausal complaints
CN100453071C (zh) * 2006-11-03 2009-01-21 李万忠 白藜芦醇口服多相脂质体及其制备方法
US20090175803A1 (en) 2008-01-08 2009-07-09 David Rubin Method and compositions for administering resveratrol and pterostilbene
FR2933871B1 (fr) * 2008-07-18 2012-12-14 Yvery Formulation destinee a ameliorer la biodisponibilite d'une molecule hydrophobe
ES2592528T3 (es) * 2010-03-12 2016-11-30 Synairgen Research Limited Interferón beta para uso en el tratamiento de enfermedades de las vías respiratorias inferiores causada por influenza
CN106581028A (zh) * 2016-11-30 2017-04-26 南宁市浩特竹鼠养殖场 一种治疗竹鼠感冒的西药及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0753359A (ja) * 1993-06-11 1995-02-28 Kao Corp リポキシゲナーゼ阻害剤
FR2778337B1 (fr) * 1998-05-05 2001-08-31 Inst Nat Sante Rech Med Antagonistes des ligands du recepteur des arylhydrocarbures
AU4084599A (en) * 1998-05-18 1999-12-06 Oklahoma Medical Research Foundation Resveratrol inhibition of myeloperoxidase
US6197834B1 (en) * 1998-09-01 2001-03-06 Northeastern Ohio Universities College Of Medicine Method of inhibiting formation of infectious herpes virus particles
CA2339049C (en) * 1998-09-08 2010-02-23 Cornell Research Foundation, Inc. Treating inflammatory diseases of the head and neck with cyclooxygenase-2 inhibitors

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007262068A (ja) * 2006-03-28 2007-10-11 Epitech Group Srl 免疫系の一般的反応により引き起こされる病態の治療のための医薬組成物
WO2008136173A1 (ja) * 2007-04-20 2008-11-13 Ochanomizu University スチルベン誘導体を有効成分とする脂肪細胞分化抑制剤
KR20140048212A (ko) 2011-06-29 2014-04-23 가부시키가이샤 롯데 눈 피로 억제 조성물 및 그것을 함유하는 음식품
JP2014530823A (ja) * 2011-10-19 2014-11-20 エヌエーディー ライフ ピーティーワイ リミテッド レスベラトロール医薬組成物

Also Published As

Publication number Publication date
WO2001008671A3 (en) 2002-05-02
WO2001008671A2 (en) 2001-02-08
HK1049104A1 (zh) 2003-05-02
CA2379703A1 (en) 2001-02-08
TR200200246T2 (tr) 2002-09-23
PE20010540A1 (es) 2001-05-15
EP1221949A2 (en) 2002-07-17
CO5200850A1 (es) 2002-09-27
CN1377262A (zh) 2002-10-30
AU6240200A (en) 2001-02-19

Similar Documents

Publication Publication Date Title
CA2356881C (en) Compositions having improved delivery of actives
ES2762806T3 (es) Tratamiento utilizando estabilizadores de mastocitos para trastornos sistémicos
US6770263B1 (en) Compositions and methods for the treatment of aches and pains
TWI336255B (en) Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiqinone and a bronchodilating agent
EP3911346B1 (en) Oral cavity treatments
JP2003505500A (ja) 風邪およびインフルエンザ様疾患に関連した症状の予防および治療のための方法および組成物
Rathod et al. Medicated lozenges as an easy to use dosage form
JP2012508772A (ja) 唾液分泌減退を緩和し口腔の快適性を提供するための組成物および方法
KR20010093256A (ko) 개선된 안정성을 갖는 조성물
WO1994025003A1 (en) Nasal aromatic releasing compositions
US20190125660A1 (en) Orally dissolving mucoadhesive films utilizing menthol and l-arginine to enhance the bioavailability of cannabinoids
US20180110723A1 (en) Pharmaceutical Compositions Comprising Flurbiprofen
PT1628673E (pt) Composições farmacêuticas compreendendo um extracto de euphorbia prostrata
TW200922600A (en) DHEAS inhalation compositions
JPH10298107A (ja) 医薬組成物
WO2019130215A1 (en) Cannabis compositions for the treatment of inflammatory skin disorders
WO2019091082A1 (zh) 一种羧甲司坦雾化吸入用溶液制剂及其制备方法
JP2018188377A (ja) 医薬組成物
WO2010009288A1 (en) Compositions and uses of antiviral active pharmaceutical agents
US20170151302A1 (en) Compositions and Methods for Alleviating Hyposalivation and for Providing Oral Comfort
TW200838524A (en) Methods for treating nasal congestion in hepatically impaired patients
JP2010538008A (ja) 呼吸器系疾患または症状を処置および予防するためのグリセロリン酸カルシウム
JP2004075571A (ja) 点鼻剤およびその製造方法
CA2017923A1 (en) Heated oral antitussive compositions
Pasternak The dental considerations of outpatient inhalation therapy

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20071002